Cargando…
A high-throughput screen to identify novel synthetic lethal compounds for the treatment of E-cadherin-deficient cells
The cell-cell adhesion protein E-cadherin (CDH1) is a tumor suppressor that is required to maintain cell adhesion, cell polarity and cell survival signalling. Somatic mutations in CDH1 are common in diffuse gastric cancer (DGC) and lobular breast cancer (LBC). In addition, germline mutations in CDH1...
Autores principales: | Beetham, Henry, Chen, Augustine, Telford, Bryony J., Single, Andrew, Jarman, Kate E., Lackovic, Kurt, Luxenburger, Andreas, Guilford, Parry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6715681/ https://www.ncbi.nlm.nih.gov/pubmed/31467357 http://dx.doi.org/10.1038/s41598-019-48929-0 |
Ejemplares similares
-
E-cadherin-deficient cells have synthetic lethal vulnerabilities in plasma membrane organisation, dynamics and function
por: Godwin, Tanis D., et al.
Publicado: (2018) -
Allosteric AKT Inhibitors Target Synthetic Lethal Vulnerabilities in E-Cadherin-Deficient Cells
por: Bougen-Zhukov, Nicola, et al.
Publicado: (2019) -
E-cadherin loss alters cytoskeletal organization and adhesion in non-malignant breast cells but is insufficient to induce an epithelial-mesenchymal transition
por: Chen, Augustine, et al.
Publicado: (2014) -
E-Cadherin-Deficient Epithelial Cells Are Sensitive to HDAC Inhibitors
por: Decourtye-Espiard, Lyvianne, et al.
Publicado: (2021) -
Cohesin mutations are synthetic lethal with stimulation of WNT signaling
por: Chin, Chue Vin, et al.
Publicado: (2020)